Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer’s disease : a 26-week, open-label prospective trial (studies ENA713B US32).